Anteris technologies yesterday announced that the first 5 patients have successfully been implanted with Anteris’s DurAVR Valve.
An additional 5 patients are planned for treatment in the first quarter of 2022 to conclude the study.
This is a massive step towards FDA approval as AVR’s technology shows:
- Avoids the need for open heart surgery
- AVR’s heart valve have shown no calcification over 10 years – therefore avoids repeat surgery, and allows younger patients to be treated
- Early signs from first 5 patients have shown DurAVR providing superior haemodynamics
- Commissural alignment, flow characteristics and haemodynamics were proven to be clinically significant
- Forums
- ASX - By Stock
- AVR
- Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve
Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve, page-48
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.00 |
Change
0.110(0.58%) |
Mkt cap ! $365.2M |
Open | High | Low | Value | Volume |
$19.01 | $19.11 | $18.59 | $97.55K | 5.216K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 43 | $19.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.50 | 21 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 43 | 19.000 |
1 | 200 | 18.800 |
1 | 1000 | 18.600 |
3 | 1475 | 18.580 |
1 | 1000 | 18.550 |
Price($) | Vol. | No. |
---|---|---|
19.500 | 21 | 1 |
20.000 | 1800 | 4 |
20.100 | 100 | 1 |
20.120 | 420 | 1 |
20.400 | 678 | 1 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online